Compare with MARKSANS PHARMA. - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ZIM LABORATORIES vs MARKSANS PHARMA. - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ZIM LABORATORIES MARKSANS PHARMA. ZIM LABORATORIES/
MARKSANS PHARMA.
 
P/E (TTM) x 38.6 9.2 421.5% View Chart
P/BV x 1.5 2.6 59.1% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 ZIM LABORATORIES   MARKSANS PHARMA.
EQUITY SHARE DATA
    ZIM LABORATORIES
Mar-21
MARKSANS PHARMA.
Mar-21
ZIM LABORATORIES/
MARKSANS PHARMA.
5-Yr Chart
Click to enlarge
High Rs13166 198.9%   
Low Rs5313 406.5%   
Sales per share (Unadj.) Rs189.233.6 562.7%  
Earnings per share (Unadj.) Rs4.55.8 77.3%  
Cash flow per share (Unadj.) Rs14.26.7 212.0%  
Dividends per share (Unadj.) Rs00.25 0.0%  
Avg Dividend yield %00.6 0.0%  
Book value per share (Unadj.) Rs99.021.7 457.0%  
Shares outstanding (eoy) m16.24409.31 4.0%   
Bonus / Rights / Conversions ---  
Price / Sales ratio x0.51.2 41.4%   
Avg P/E ratio x20.56.8 301.4%  
P/CF ratio (eoy) x6.55.9 109.9%  
Price / Book Value ratio x0.91.8 51.0%  
Dividend payout %04.3 0.0%   
Avg Mkt Cap Rs m1,49716,188 9.2%   
No. of employees `000NANA-   
Total wages/salary Rs m3581,973 18.1%   
Avg. sales/employee Rs ThNMNM-  
Avg. wages/employee Rs ThNMNM-  
Avg. net profit/employee Rs ThNMNM-  
INCOME DATA
Net Sales Rs m3,07313,762 22.3%  
Other income Rs m2367 34.9%   
Total revenues Rs m3,09613,829 22.4%   
Gross profit Rs m3463,396 10.2%  
Depreciation Rs m158362 43.7%   
Interest Rs m10980 136.5%   
Profit before tax Rs m1023,022 3.4%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m29636 4.6%   
Profit after tax Rs m732,385 3.1%  
Gross profit margin %11.324.7 45.6%  
Effective tax rate %28.521.1 135.3%   
Net profit margin %2.417.3 13.7%  
BALANCE SHEET DATA
Current assets Rs m1,9189,023 21.3%   
Current liabilities Rs m1,4202,984 47.6%   
Net working cap to sales %16.243.9 36.9%  
Current ratio x1.43.0 44.7%  
Inventory Days Days161 1,424.4%  
Debtors Days Days85871,977,516 0.0%  
Net fixed assets Rs m1,3043,252 40.1%   
Share capital Rs m162409 39.7%   
"Free" reserves Rs m1,4458,456 17.1%   
Net worth Rs m1,6088,865 18.1%   
Long term debt Rs m2180-   
Total assets Rs m3,22212,275 26.2%  
Interest coverage x1.938.8 5.0%   
Debt to equity ratio x0.10-  
Sales to assets ratio x1.01.1 85.1%   
Return on assets %5.720.1 28.2%  
Return on equity %4.626.9 16.9%  
Return on capital %11.635.0 33.1%  
Exports to sales %67.40-   
Imports to sales %4.17.4 56.3%   
Exports (fob) Rs m2,072NA-   
Imports (cif) Rs m1271,014 12.6%   
Fx inflow Rs m2,1405,874 36.4%   
Fx outflow Rs m1271,014 12.6%   
Net fx Rs m2,0124,860 41.4%   
CASH FLOW
From Operations Rs m3191,787 17.8%  
From Investments Rs m-59-449 13.1%  
From Financial Activity Rs m-260-153 169.9%  
Net Cashflow Rs m-11,186 -0.1%  

Share Holding

Indian Promoters % 33.3 48.3 68.9%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 3.0 -  
FIIs % 0.0 2.6 -  
ADR/GDR % 0.0 0.0 -  
Free float % 66.7 51.8 129.0%  
Shareholders   3,646 214,998 1.7%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ZIM LABORATORIES With:   SUN PHARMA    LUPIN    CIPLA    AUROBINDO PHARMA    DR. REDDYS LAB    



Today's Market

5 Reasons Why Sensex Crashed 1,546 Points Today(Closing)

Indian share markets witnessed heavy selling pressure today and ended deep in the red. The sell-off continued for the fifth straight session today with benchmark indices losing nearly 3% each.

Related Views on News

MARKSANS PHARMA. 2020-21 Annual Report Analysis (Annual Result Update)

Nov 9, 2021 | Updated on Nov 9, 2021

Here's an analysis of the annual report of MARKSANS PHARMA. for 2020-21. It includes a full income statement, balance sheet and cash flow analysis of MARKSANS PHARMA.. Also includes updates on the valuation of MARKSANS PHARMA..

Sun Pharma vs Dr Reddy's: Which is Better? (Views On News)

Dec 16, 2021

In an extremely competitive market, two pharma companies are competing against each other to grab the top spot.

5 Stocks to Watch Out for Amid the Omicron Outbreak (Views On News)

Dec 3, 2021

As the new variant of Covid-19 emerges, keep an eye on these stocks.

This Stock Just Made a Historical Debut on the Exchanges (Views On News)

Nov 15, 2021

Shares of the company listed at premium of 253% from its IPO price, the highest ever.

3 Indian Pharma Companies that are Investing Big Time for the Future (Views On News)

Nov 9, 2021

In 2021, R&D of pharma companies roared to life in a never-before-seen way.

More Views on News

Most Popular

Tata Steel vs SAIL: Which Stock is Better?(Views On News)

Jan 13, 2022

With government initiatives set to boost the steel sector, find out who has a better chance of coming out on top.

Watch Out for these 4 Indian Companies Betting Big on EV Supply Chain(Views On News)

Jan 11, 2022

The upside in supply chain players could be huge but a delay in the transition to EVs, or any policy related hiccups could end the momentum.

These 5 Penny Stocks are Held by Rakesh Jhunjhunwala. Worth a Look?(Views On News)

Jan 18, 2022

Rakesh Jhunjhunwala is holding these penny stocks in his portfolio for several years now.

Tech Mahindra's CTC Acquisition: Too Expensive?(Views On News)

Jan 18, 2022

Tech Mahindra's acquisition of European IT-company fails to excite investors.

Time to Buy Energy Stocks(Fast Profits Daily)

Jan 14, 2022

Energy is a sector that looks set to take off. It's time to get in.

More

Become A Smarter Investor
In Just 5 Minutes

Multibagger Stock Guide 2022
Get our special report Multibagger Stocks Guide (2022 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

ZIM LABORATORIES SHARE PRICE


Jan 24, 2022 (Close)

TRACK ZIM LABORATORIES

  • Track your investment in ZIM LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON ZIM LABORATORIES

ZIM LABORATORIES 5-YR ANALYSIS

COMPARE ZIM LABORATORIES WITH

MARKET STATS